spikevax (previously covid-19 vaccine moderna)
moderna biotech spain, s.l. - single-stranded, 5’-capped messenger rna (mrna) produced using a cell-free in vitro transcription from the corresponding dna templates, encoding the viral spike (s) protein of sars-cov-2 - covid-19 virus infection - vaccini - spikevax is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 6 months of age and older. spikevax bivalent original/omicron ba. 1 is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 6 years of age and older who have previously received at least a primary vaccination course against covid-19. spikevax bivalent original/omicron ba. 4-5 is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 6 months of age and older. spikevax xbb. 5 is indicated for active immunisation to prevent covid 19 caused by sars-cov-2 in individuals 6 months of age and older. the use of this vaccine should be in accordance with official recommendations.
adorea
abiogen pharma s.p.a. - codeina, associazioni - codeina, associazioni
co efferalgan
medifarm s.r.l. - codeina e paracetamolo - codeina e paracetamolo
co-dafalgan compresse effervescenti
upsa switzerland ag - paracetamolum, codeini phosphas hemihydricus - compresse effervescenti - paracetamolum 500 mg, codeini phosphas hemihydricus 30 mg, natrii hydrogenocarbonas, natrii carbonas, acidum citricum, natrii docusas, povidonum, aromatica, sorbitolum 300 mg, aspartamum 30 mg, e 211 58.5 mg pro compresso corresp. natrium 384.7 mg. - analgesico - synthetika
co-dafalgan compresse rivestite con film
upsa switzerland ag - paracetamolum, codeini phosphas hemihydricus - compresse rivestite con film - paracetamolum 500 mg, codeini phosphas hemihydricus 30 mg, povidonum, cellulosum microcristallinum, carmellosum natricum conexum, magnesii stearas, Überzug: hypromellosum, propylenglycolum, e 171 pro compresso obducto corresp. natrium 2.1 mg. - analgesico - synthetika
escotussin gocce
streuli pharma ag - dihydrocodeini thiocyanas, guaifenesinum, belladonnae colorante normata, droserae estratto liquido - gocce - dihydrocodeini thiocyanas 10 mg, guaifenesinum 92.5 mg, belladonnae colorante normata 10 mg, droserae estratto liquido di 10 mg, arom.: natrii cyclamas, saccharinum, vanillinum e altri, excipiens ad una soluzione per 1 ml, corrisp. 35 gocce, corrisp. ethanolum 34 % v/v. - tosse - synthetika
husten- und bronchialsirup s mit zucker
hänseler ag - codeini phosphas hemihydricus, droserae tinctura, hyoscyami tinctura, liquiritiae extractum liquidum, primulae radicis extractum liquidum - mit zucker - codeini phosphas hemihydricus 4.2 mg, droserae tinctura 36 mg, hyoscyami tinctura 6 mg, liquiritiae extractum liquidum 150 mg, primulae radicis extractum liquidum 30 mg, saccarosio, aromatica, colore.: e-150, tenuto.: e 216, e 218, e 211, excipiens annuncio solutionem pro 5 ml corrisp. ethanolum 1.4 % v/v. - husten - synthetika
iropect bronchialpastillen lutschpastillen
tentan ag - codeini phosphas hemihydricus - lutschpastillen - codeini phosphas hemihydricus 3 mg, arom.: eucalipti, aetheroleum, al balsamo tolutani sirupus, anisi stellati aetheroleum, levomentholum, anisi aetheroleum, succo di liquirizia, aspartamum, colore.: e 150a, conserv.: e 202, e 219, excipiens per la torta. - tosse - synthetika
codicalm sirup
dr. heinz welti ag, fabrikation chemisch-pharmazeutischer produkte - codeini phosphas hemihydricus - sirup - codeini phosphas hemihydricus 15 mg, carmellosum natricum corresp. natrium 13.2 mg, sorbitolum liquidum non cristallisabile 7.5 g, acidum citricum, aromatica, e 210 15 mg, aqua purificata ad solutionem pro 15 ml. - tosse - synthetika
coditussin bronchialpastillen
dr. heinz welti ag, fabrikation chemisch-pharmazeutischer produkte - codeini phosphas hemihydricus - bronchialpastillen - codeini phosphas hemihydricus 5 mg sono di colore.: e 150c, excipiens per la torta. - in caso di raffreddore tosse stizzosa - synthetika